Pneumococcal infections, caused by the bacterium Streptococcus pneumoniae, remain a significant global public health concern. This Gram-positive bacterium is a leading cause of respiratory tract infections, including pneumonia, otitis media, and sinusitis. Pneumococcal infections can also lead to invasive diseases such as bacteremia and meningitis, particularly in vulnerable populations such as young children, the elderly, and individuals with weakened immune systems. Transmission of S. pneumoniae occurs through respiratory droplets, and colonization in the nasopharynx is common, especially in children. The bacterium possesses various virulence factors, including a polysaccharide capsule that aids in evading the host immune system. When infection occurs, the clinical presentation can vary widely, ranging from mild upper respiratory symptoms to severe pneumonia or life-threatening invasive diseases. Preventive measures for pneumococcal infections include vaccination, with pneumococcal conjugate vaccines (PCVs) and pneumococcal polysaccharide vaccines (PPVs) targeting different age groups. Vaccination has led to a significant reduction in the incidence of pneumococcal diseases, highlighting the importance of immunization in public health efforts.